Executive Profiles
MICHEL MORAVIA
MSE, MBA
Chief Executive Officer
Michel E. Moravia, CEO, WBJ Top 40 Under 40: Product Executive and Quality Leader with 15+ years of experience working for Fortune 100 companies (AbbVie/Amgen/Novartis) in the pharmaceutical/medical device industry, where he successfully brought multiple prominent drugs/devices/combination products to market. At QMB, he is responsible for overall business strategy and operations. Michel is an ISO 13485:2016 Certified Lead Auditor and has instituted lean programs as a Master Black Belt that have realized savings of $6.5 million+ for Danaher Corporation. Michel fundamentally believes quality makes the human experience better. Michel holds a Master of Science in Product Design Engineering and an MBA in Health Sector Management from Boston University.
CHRISTOPHER WALLACE
PHARMD
Chief Technical Officer
Christopher J Wallace, CTO, has been with CVS/pharmacy for 10+ years and 15+ years of experience as a programmer. During his tenure as pharmacy manager, he increased turnover two-fold in less than a year while being awarded for excellence in customer service. At QMB, Chris is responsible for ensuring technology needs meet current and future business requirements while adhering to industry best practices for information security. Chris believes that the integration of quality-centric, user-friendly technology will improve patient outcomes while simultaneously reducing costs. Chris holds a Doctor of Pharmacy from Massachusetts College of Pharmacy and Health Sciences.
THAINA C. MORAVIA-ROMAN
MSN, ARNP-BC
Chief Operating Officer
Thaina C. Moravia-Roman, COO, has 10+ years of experience within the medical industry. She provides primary care to 700+ patient panels while serving on a Governance Quality Committee. In addition, she has presented at multiple medical conferences and delivered presentations on heart disease risks and prevention within the African American Community, as well as De-escalation of Care modalities towards the end of life. At QMB, Thaina ensures collaboration between the Executive Leadership Team and assures policies from legal counsel and financial services meet business strategy. Thaina is passionate about quality as she knows it will mold a more sustainable future towards medical progress and innovation. Thaina holds a Master of Science Degree in Nursing from the MGH Institute of Health Professions.
SRINIVAS PALEPU
MSCS, MBA
Chief Product Officer
Srinivas Palepu, CPO, specializes in digital transformation and business growth. He is an Executive that drives corporations to implement technologies that streamline operations, enhance productivity, and maximize profitability. Srinivas has 20+ years of experience in the Information Technology industry, working for Fortune 500 global companies in various technology leadership roles, ensuring top-notch security, and setting dynamic yet robust product architectures. In addition, he’s a certified Practitioner for AWS Cloud and Microsoft Azure AI. At QMB, Srini is responsible for bringing product innovation by identifying emerging technologies that fuel the products’ value propositions. Srini’s passion lies at the intersection of business and technology and leveraging cutting-edge solutions to create maximum competitive advantage for the organization. Srini holds MBA from Boston University and a Master’s in computer science from Osmania University.
JERRY LIU
PH.D.
Chief Scientific Officer
Jerry Liu, CSO: Dedicated research and development scientist with 10+ years of combined biotech industry, reference laboratory, and academia experience. He has spearheaded numerous manufacturing and quality control process improvements that resulted in a more robust and sustainable production environment. At QMB, he is responsible for prescribing customized quality solutions based on the scientific foundation upon which drug-device combination products are built. Jerry is passionate about manifesting new scientific discoveries into marketable products that would ultimately improve the quality of people's lives. Jerry holds a Doctorate of Philosophy in Biomedical Engineering and Bio-Informatics and a Master of Science in Clinical Laboratory Sciences from the University of Massachusetts Lowell.
SIMING XU
MSE, MBA
Chief Commercial Officer
Siming Xu, CCO, MBA, MSE: Commercial Leader with 15+ years of experience in the Pharmaceutical, Biopharmaceutical, Analytical Instrument, and Medical Devices industries with many successes in driving the commercial engine through Sales and Marketing Planning, Go-to-Market strategy, Commercial Execution Optimization as well as Business Turnaround strategy and roadmap. As CCO of QMB, Siming is the owner of overall commercial strategy and execution. He is passionate about challenging the status quo, driving continuous improvement in the quality world, and strongly believes in the improvement of life quality via positive changes brought by QMB. Siming has a Master of Engineering degree from Tongji University and an MBA from the University of Virginia.
Bryan Saint-Louis
Vice President/General Manager
Bryan R. Saint-Louis, VP/GM, is a subject matter expert in biopharmaceuticals that has worn multiple hats in the cell/viral gene therapy sector over the past six years. Bryan has 10+ years of experience within the healthcare industry with a technical acumen relating to Supply Planning, Quality Assurance, and Regulatory Affairs. Throughout his career, Bryan has successfully assisted two Fortune 500 companies in launching novel gene therapies via cross-functional quality and supply planning support. At QMB, Bryan oversees company management, product life cycles and ensures all functional groups maintain industry best practices. Quality is safe in the hands of Bryan as he has a heavy emphasis on risk management and a solid understanding of regulatory guidelines. Bryan has received a Bachelor's Degree in Biochemistry from the University of Massachusetts Dartmouth.